Abstract
La Agencia Europea de Medicamentos rechaza la autorización del aducanumab para la enfermedad de Alzheimer.
MeSH terms
-
Alzheimer Disease* / drug therapy
-
Amyloid beta-Peptides
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
Humans
Substances
-
Amyloid beta-Peptides
-
Antibodies, Monoclonal, Humanized
-
aducanumab